Integrated Filing — IndAS



General information about company
Scrip Code 507747
NSE Symbol TTKHLTCARE
MSEI Symbol NOTLISTED
ISIN INE910C01018
Name of company TTK HEALTHCARE LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-Apr-2025
Date of end of financial year 31-Mar-2026
Date of board meeting when results were approved 04-Aug-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange
Description of presentation currency INR (in Actuals)
Reporting Type Quarterly
Reporting Quarter First quarter
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 04-Aug-2025   12:00:00
End date and time of board meeting 04-Aug-2025   12:50:00
Whether cash flow statement is applicable on company
Type of cash flow statement
Declaration of unmodified opinion or statement on impact of audit qualification Not applicable
Whether the company has any related party?
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.
Whether the company is a high value debt listed entity according to regulation 15 (1A)?
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?
Latest Date on which RPT policy is updated
Indicate Company website link for updated RPT policy of the Company
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
There is no Default on loans and Debt Securities, hence Not Applicable



Financial Results Ind-AS
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Income
Revenue from operations 2264298000
Other income 179356000
Total income 2443654000
2 Expenses
(a) Cost of materials consumed 495672000
(b) Purchases of stock-in-trade 470274000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 52240000
(d) Employee benefit expense 413308000
(e) Finance costs 7696000
(f) Depreciation, depletion and amortisation expense 21881000
(f) Other Expenses
1 Other Expenses 806048000 806048000
Total other expenses 806048000
Total expenses 2267119000
3 Total profit before exceptional items and tax 176535000
4 Exceptional items 0
5 Total profit before tax 176535000
6 Tax expense
7 Current tax 46500000
8 Deferred tax 41000
9 Total tax expenses 46541000
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0
11 Net Profit Loss for the period from continuing operations 129994000
12 Profit (loss) from discontinued operations before tax 0
13 Tax expense of discontinued operations 0
14 Net profit (loss) from discontinued operation after tax 0
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0
16 Total profit (loss) for period 129994000
17 Other comprehensive income net of taxes 5719000
18 Total Comprehensive Income for the period 135713000
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent
Total comprehensive income for the period attributable to owners of parent non-controlling interests
21 Details of equity share capital
Paid-up equity share capital 141303000
Face value of equity share capital 10
27 Details of debt securities
22 Reserves excluding revaluation reserve
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 9.2
Diluted earnings (loss) per share from continuing operations 9.2
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0
Diluted earnings (loss) per share from discontinued operations 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 9.2
Diluted earnings (loss) per share from continuing and discontinued operations 9.2
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results
Textual Information(1) 1 The above financial results for the First Quarter ended June 30 2025 in respect of TTK Healthcare Limited the Company have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their respective meetings held on August 04 2025 at the Registered Office of the Company also with the provision of Video Conferencing facility n n2 The Statutory Auditors of the Company have carried out Limited Review of the above Unaudited Financial Results in terms of Regulations 33 of the SEBI Listing Obligations and Disclosure Requirements Regulations 2015 n n3 a During the first quarter of the previous year the Company had sold Leasehold land with building at Mahindra World City Chennai for a consideration of Rs 2300 lakhs and the profit on sale amounting to Rs 197705 lakhs Net has been considered in the above results n nb During the fourth quarter of the previous year the Company had written off the entire value of Male Contraceptives pertaining to the Protective Devices Division amounting to Rs 58639 lakhs that were meant for export under USAID Program owing to a 90 day pause on foreign development assistance and subsequent cancellation of Purchase Orders as the inventory was custom made and not marketable to alternate buyers n n4 The figures for the Quarter ended March 31 2025 are the balancing figures between the Audited Figures in respect of the full financial year and the published year to date figures up to the end of the Third Quarter of the relevant financial year which were subjected to Limited Review n n5 The previous periods years figures have been regrouped and reclassified wherever necessary to conform to the current periods years presentation n n6 The full financial results for the First Quarter ended June 30 2025 are available on the website of BSE Limited www bseindia com National Stock Exchange of India Limited www nseindia com and also on the website of the Company www ttkhealthcare com n



Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2025
Date of end of reporting period 30-Jun-2025
Whether accounts are audited or unaudited Unaudited
Nature of report standalone or consolidated Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Animal Welfare 318839000 318839000
2 Consumer Products 756304000 756304000
3 Medical Devices 288680000 288680000
4 Protective Devices 527124000 527124000
5 Foods 372433000 372433000
6 Others 918000 918000
Total Segment Revenue 2264298000
Less: Inter segment revenue 0 0
Revenue from operations 2264298000
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Animal Welfare 23413000 23413000
2 Consumer Products 12571000 12571000
3 Medical Devices 80681000 80681000
4 Protective Devices -54434000 -54434000
5 Foods 29411000 29411000
6 Others 782000 782000
Total Profit before tax 92424000
i. Finance cost 7696000 7696000
ii. Other Unallocable Expenditure net off Unallocable income -91807000 -91807000
Profit before tax 176535000
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Animal Welfare 397040000 397040000
2 Consumer Products 503332000 503332000
3 Medical Devices 827100000 827100000
4 Protective Devices 1385190000 1385190000
5 Foods 673807000 673807000
6 Others 29602000 29602000
Total Segment Asset 3816071000 3816071000
Un-allocable Assets 9292586000 9292586000
Net Segment Asset 13108657000 13108657000
4 Segment Liabilities
Segment Liabilities
1 Animal Welfare 276903000 276903000
2 Consumer Products 646254000 646254000
3 Medical Devices 181950000 181950000
4 Protective Devices 427446000 427446000
5 Foods 158740000 158740000
6 Others 13643000 13643000
Total Segment Liabilities 1704936000 1704936000
Un-allocable Liabilities 617526000 617526000
Net Segment Liabilities 2322462000 2322462000
Disclosure of notes on segments Textual Information(2)



Text Block
Textual Information(2) Notes n1 Segments have been identified in line with the Indian Accounting Standard on Segment Reporting Ind AS 108 based on review of performance by the Top Management n2 Details of products included in each of the Segments are as below nAnimal Welfare comprise products for Veterinary use nConsumer Products comprise marketing and distribution of Woodwards Gripewater EVA Range of Cosmetics Good Home Range of Scrubbers Air Fresheners etc nMedical Devices include Artificial Heart Valves Orthopaedic Implants etc nProtective Devices comprise manufacturing and marketing of Male Contraceptives and other allied products nFoods comprise manufacturing and marketing of Food Products nOthers include Printing and Publishing of Maps and Atlases n3 The segment wise revenue results assets and liabilities figures relate to respective amounts directly identifiable to each of the segments The unallocable expenditure includes expenses incurred on common services at the corporate level and also those expenses not identifiable to any specific segment n4 The previous periods years figures have been regrouped and reclassified wherever necessary to conform to the current periods years presentation



Other Comprehensive Income
Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Apr-2025
B Date of end of reporting period 30-Jun-2025
C Whether results are audited or unaudited Unaudited
D Nature of report standalone or consolidated Standalone
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Items that will not be reclassified subsequently to profit or loss 5945000 5945000
Total Amount of items that will not be reclassified to profit and loss 5945000
2 Income tax relating to items that will not be reclassified to profit or loss 226000
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss 0
5 Total Other comprehensive income 5719000